- Home
- HAS vs ASND Comparison
HAS vs ASND Comparison
Compare HAS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAS | ASND |
|---|---|---|
| Founded | 1923 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | 1189 |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 17.1B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HAS | ASND |
|---|---|---|
| Price | $122.00 | $267.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 21 |
| Target Price | $119.08 | ★ $304.82 |
| AVG Volume (30 Days) | ★ 2.5M | 607.1K |
| Earning Date | 10-20-2026 | 11-12-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.27 | N/A |
| Revenue | ★ $5,365,900,000.00 | N/A |
| Revenue This Year | $9.88 | $89.94 |
| Revenue Next Year | $7.20 | $46.86 |
| P/E Ratio | $23.55 | ★ N/A |
| Revenue Growth | ★ 13.06 | N/A |
| 52 Week Low | $74.78 | $188.08 |
| 52 Week High | $124.62 | $282.15 |
Technical Indicators
Market Signals| Indicator | HAS | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 74.05 | 70.55 |
| Support Level | $87.99 | $216.52 |
| Resistance Level | N/A | $272.47 |
| Average True Range (ATR) | 3.00 | 6.24 |
| MACD | -0.25 | 1.74 |
| Stochastic Oscillator | 74.16 | 91.77 |
Price Performance
Historical ComparisonAbout HAS Hasbro Inc.
Hasbro is a branded play company that provides children and families worldwide with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and licensing, Hasbro reaches customers by leveraging well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, adding Dungeons & Dragons Beyond in 2022 gave the firm access to a digital game platform with millions of registered accounts.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.